UnitedHealth Group (NYSE:UNH) Raised to Strong-Buy at Evercore ISI
by Danessa Lincoln · The Markets DailyUnitedHealth Group (NYSE:UNH – Get Free Report) was upgraded by analysts at Evercore ISI to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.
Other equities analysts have also issued reports about the company. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. KeyCorp boosted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Finally, Royal Bank Of Canada upped their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.75.
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Trading Down 2.0%
Shares of UNH stock opened at $341.96 on Tuesday. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business’s 50 day moving average is $329.42 and its two-hundred day moving average is $320.61. The company has a market cap of $309.76 billion, a PE ratio of 17.85, a price-to-earnings-growth ratio of 2.11 and a beta of 0.42.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the firm posted $7.15 EPS. Equities analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.
Hedge Funds Weigh In On UnitedHealth Group
A number of large investors have recently added to or reduced their stakes in UNH. Murphy Pohlad Asset Management LLC boosted its stake in UnitedHealth Group by 21.8% during the second quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after buying an additional 791 shares during the period. Carnegie Investment Counsel boosted its holdings in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock valued at $36,471,000 after acquiring an additional 2,316 shares during the last quarter. Berkshire Hathaway Inc acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $1,572,193,000. Triumph Capital Management acquired a new stake in UnitedHealth Group during the second quarter worth about $1,324,000. Finally, Wealth Effects LLC grew its position in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group News Summary
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Analyst confidence has been rising, recasting UNH’s investment story toward a steadier, buy-and-hold narrative as analysts point to durable cash flow and margin resilience. This supports multiple expansion and institutional demand. How Rising Analyst Confidence At UnitedHealth Group (UNH) Has Changed Its Investment Story
- Positive Sentiment: Motley Fool included UNH among top Dow picks for 2026, highlighting long-term growth drivers (Medicare Advantage, Optum services) that can attract buy-side interest and support the stock. 2 Dow Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid
- Positive Sentiment: An analyst named UNH a top pick and nudged up its price target, a catalyst that likely supported earlier intraday buying and underpins upside expectations versus peers. Why UnitedHealth Stock Bumped Higher Today
- Positive Sentiment: Evercore upgraded UNH to Outperform despite noting elevated utilization trends — the upgrade signals confidence in management’s ability to manage costs and sustain growth, which can attract buyers. UnitedHealth wins outperform at Evercore despite elevated utilization trends
- Neutral Sentiment: Some analysts are reworking the earnings-recovery narrative, tempering near-term growth expectations as utilization patterns fluctuate; this introduces near-term uncertainty even as the longer-term thesis remains intact. Looking At The Narrative For UnitedHealth Group UNH After Shifting Earnings Recovery Expectations
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026